Vis enkel innførsel

dc.contributor.authorRobsahm, Trude Eiden_US
dc.contributor.authorHelsing, Peren_US
dc.contributor.authorNilssen, Yngvaren_US
dc.contributor.authorVos, Lindaen_US
dc.contributor.authorRizvi, Syed Mohammad Husainen_US
dc.contributor.authorAkslen, Lars A.en_US
dc.contributor.authorVeierød, Marit Bragelienen_US
dc.date.accessioned2019-05-28T12:17:02Z
dc.date.available2019-05-28T12:17:02Z
dc.date.issued2018-05-09
dc.PublishedRobsahm R, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LA, Veierød MB. High mortality due to cutaneous melanoma in norway: A study of prognostic factors in a nationwide cancer registry. Clinical Epidemiology. 2018;10:537-548eng
dc.identifier.issn1179-1349
dc.identifier.urihttps://hdl.handle.net/1956/19770
dc.description.abstractPurpose: The purpose of this study was to examine why Norway has the highest rate of mortality due to cutaneous melanoma (CM) in Europe. The Norwegian Malignant Melanoma Registry (NMMR) enables the study of clinical and histopathological characteristics of patients who die due to CM. Patients and methods: The NMMR and the Norwegian Cause of Death Registry provided data on the clinical and histopathological factors as well as the date and cause of death, through June 2015 for all first invasive CMs diagnosed in 2008–2012 (n=8087). Cox regression was used to estimate associations between clinical and pathological factors and CM-specific death. Multiple imputation was used to handle missing data. Results: The CMs were equally distributed between men (49.9%) and women (50.1%), and the median follow-up was 4.0 years (range: 0.08–7.5 years). Trunk was the most common anatomic site (48%), superficial spreading melanoma was the dominant melanoma subtype (68.2%), median Breslow thickness was 1.0 mm, ulceration was present in 23% of CMs, and 91.8% of cases were in a local clinical stage at diagnosis. Compared to women, men were diagnosed at a higher age, with thicker and more-often-ulcerated tumor, and more often were in advanced clinical stages. During follow-up, 1015 patients died due to CM, representing 52.8% of all deaths. The nodular subtype made up the dominant proportion of fatal CM cases (55.3% in women, 64.6% in men). Sex, age, anatomic site (trunk), T-stage, ulceration, clinical stage, and having a second primary CM were associated with increased risk of CM-specific death. Conclusion: Our data suggest that the high rate of mortality due to CM observed in Norway is attributable to the more advanced stage of the disease at diagnosis. Most high-risk cases occurred in male patients ≥70 years of age. Efforts to improve awareness and secondary prevention of CM, including warning signs of all melanoma subtypes, are required urgently and should be targeted toward men in particular.en_US
dc.language.isoengeng
dc.publisherDove Presseng
dc.rightsAttribution CC BY-NCeng
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/eng
dc.subjectcutaneous melanomaeng
dc.subjectMortalityeng
dc.subjectprognostic factorseng
dc.subjectdiagnostic delayeng
dc.subjectEpidemiologyeng
dc.titleHigh mortality due to cutaneous melanoma in norway: A study of prognostic factors in a nationwide cancer registryen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2019-01-15T12:38:32Z
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2018 The Author(s)
dc.identifier.doihttps://doi.org/10.2147/clep.s151246
dc.identifier.cristin1593504
dc.source.journalClinical Epidemiology


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY-NC
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY-NC